91 related articles for article (PubMed ID: 10492668)
1. Increased incidence of cycloguanil resistance in malaria cases entering France from Africa, determined as point mutations in the parasites' dihydrofolate-reductase genes.
Durand R; di Piazza JP; Longuet C; Sécardin Y; Clain J; le Bras J
Ann Trop Med Parasitol; 1999 Jan; 93(1):25-30. PubMed ID: 10492668
[TBL] [Abstract][Full Text] [Related]
2. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
Basco LK; Ringwald P
Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
[TBL] [Abstract][Full Text] [Related]
3. DHFR gene point mutation as a predictor of Plasmodium falciparum resistance to cycloguanil in malaria cases from Africa imported to France.
Durand R; Ramiliarisoa O; Sécardin Y; Eldin de Pécoulas P; Basco LK; Le Bras J
Trans R Soc Trop Med Hyg; 1997; 91(4):460-1. PubMed ID: 9373655
[No Abstract] [Full Text] [Related]
4. [Resistance to chloroquine and cycloguanil of Plasmodium falciparum in patients arriving in France after travel in Africa without chemoprophylaxis].
Le Bras J; Pradines B; di Piazza JP; Durand R; Godineau N; Bouchaud O; Roué R; Marchou B; Martet G; Longuet C; Parzy D
Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):490-2. PubMed ID: 10078392
[TBL] [Abstract][Full Text] [Related]
5. Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana.
Muehlen M; Schreiber J; Ehrhardt S; Otchwemah R; Jelinek T; Bienzle U; Mockenhaupt FP
Trop Med Int Health; 2004 Mar; 9(3):361-3. PubMed ID: 14996365
[TBL] [Abstract][Full Text] [Related]
6. Antifolate drug resistance and point mutations in Plasmodium falciparum in Kenya.
Khan B; Omar S; Kanyara JN; Warren-Perry M; Nyalwidhe J; Peterson DS; Wellems T; Kaniaru S; Gitonga J; Mulaa FJ; Koech DK
Trans R Soc Trop Med Hyg; 1997; 91(4):456-60. PubMed ID: 9373654
[TBL] [Abstract][Full Text] [Related]
7. Proguanil resistance in Plasmodium falciparum African isolates: assessment by mutation-specific polymerase chain reaction and in vitro susceptibility testing.
Parzy D; Doerig C; Pradines B; Rico A; Fusai T; Doury JC
Am J Trop Med Hyg; 1997 Dec; 57(6):646-50. PubMed ID: 9430520
[TBL] [Abstract][Full Text] [Related]
8. Late clinical failure associated with cytochrome b codon 268 mutation during treatment of falciparum malaria with atovaquone-proguanil in traveller returning from Congo.
Massamba L; Madamet M; Benoit N; Chevalier A; Fonta I; Mondain V; Jeandel PY; Amalvict R; Delaunay P; Mosnier J; Marty P; Pomares C; Pradines B
Malar J; 2020 Jan; 19(1):37. PubMed ID: 31964401
[TBL] [Abstract][Full Text] [Related]
9. Molecular epidemiology of malaria in Yaounde, Cameroon I. Analysis of point mutations in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum.
Basco LK; Ringwald P
Am J Trop Med Hyg; 1998 Mar; 58(3):369-73. PubMed ID: 9546421
[TBL] [Abstract][Full Text] [Related]
10. Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea.
Reeder JC; Rieckmann KH; Genton B; Lorry K; Wines B; Cowman AF
Am J Trop Med Hyg; 1996 Aug; 55(2):209-13. PubMed ID: 8780462
[TBL] [Abstract][Full Text] [Related]
11. Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.
Happi CT; Gbotosho GO; Folarin OA; Milner D; Sarr O; Sowunmi A; Kyle DE; Milhous WK; Wirth DF; Oduola AM
Malar J; 2006 Oct; 5():82. PubMed ID: 17020611
[TBL] [Abstract][Full Text] [Related]
12. [Monitoring the chemoresistance of Plasmodium falciparum malaria in Yopougon (Abidjan): in vivo study of chloroquine sensitivity and evaluation of pyrimethamine resistance following the analysis of point mutation in the dihydrofolate reductase gene].
Djaman AJ; Basco LK; Mazabraud A
Sante; 2002; 12(4):363-7. PubMed ID: 12626289
[TBL] [Abstract][Full Text] [Related]
13. Cycloguanil and its parent compound proguanil demonstrate distinct activities against Plasmodium falciparum malaria parasites transformed with human dihydrofolate reductase.
Fidock DA; Nomura T; Wellems TE
Mol Pharmacol; 1998 Dec; 54(6):1140-7. PubMed ID: 9855645
[TBL] [Abstract][Full Text] [Related]
14. Plasmodium falciparum dihydrofolate reductase Val-16 and Thr-108 mutation associated with in vivo resistance to antifolate drug: a case study.
Biswas S
Indian J Malariol; 2001; 38(3-4):76-83. PubMed ID: 12125519
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic efficacy of proguanil against falciparum and vivax malaria independent of the metabolite cycloguanil.
Kaneko A; Bergqvist Y; Takechi M; Kalkoa M; Kaneko O; Kobayakawa T; Ishizaki T; Björkman A
J Infect Dis; 1999 Apr; 179(4):974-9. PubMed ID: 10068594
[TBL] [Abstract][Full Text] [Related]
16. Use of a semi-nested PCR diagnosis test to evaluate antifolate resistance of Plasmodium falciparum isolates.
Eldin de Pecoulas P; Abdallah B; Dje MK; Basco LK; le Bras J; Mazabraud A
Mol Cell Probes; 1995 Dec; 9(6):391-7. PubMed ID: 8808309
[TBL] [Abstract][Full Text] [Related]
17. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa.
Plowe CV; Djimde A; Bouare M; Doumbo O; Wellems TE
Am J Trop Med Hyg; 1995 Jun; 52(6):565-8. PubMed ID: 7611566
[TBL] [Abstract][Full Text] [Related]
18. Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker.
Schwöbel B; Alifrangis M; Salanti A; Jelinek T
Malar J; 2003 Mar; 2():5. PubMed ID: 12665429
[TBL] [Abstract][Full Text] [Related]
19. [Presence of pyrimethamine and cycloguanil resistance genotype in West Africa? Evidence of a single mutation 59Arg in the dhfr gene of Plasmodium falciparum].
Pinheiro L; Rosário VE
Acta Med Port; 2003; 16(4):235-8. PubMed ID: 22226208
[TBL] [Abstract][Full Text] [Related]
20. Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season.
Alareqi LMQ; Mahdy MAK; Lau YL; Fong MY; Abdul-Ghani R; Mahmud R
Acta Trop; 2016 Oct; 162():174-179. PubMed ID: 27343362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
